We and others have previously shown that EphA2 controls NSCLC cell survival, cell death, migration and response to EGFR-TKI or VEGFR2-targeting on tumor cells [25,26,27,28,29,30,31,32,34]. This evidence concerns the gene KDR and non-small cell lung carcinoma.